U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 212 books (762 items)

1.
StatPearls [Internet].

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2025 Jan-.

2.
GeneReviews® [Internet].

GeneReviews® [Internet].

Adam MP, Feldman J, Mirzaa GM, et al., editors.

Seattle (WA): University of Washington, Seattle; 1993-2025.

3.
Conference on Hemoglobin: 2–3 May 1957.

Conference on Hemoglobin: 2–3 May 1957.

National Academy of Sciences (US) and National Research Council (US) Division of Medical Sciences.

Washington (DC): National Academies Press (US); 1958.

4.
Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action.

Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action; Martinez RM, Osei-Anto HA, McCormick M, editors.

Washington (DC): National Academies Press (US); 2020 Sep 10.

5.
Newborn screening for sickle cell disease (SCD): IQWiG Reports – Commission No. S18-01 [Internet].

Newborn screening for sickle cell disease (SCD): IQWiG Reports – Commission No. S18-01 [Internet].

Institute for Quality and Efficiency in Health Care (IQWiG).

Cologne (Germany): Institute for Quality and Efficiency in Health Care (IQWiG); 2019 Nov 28.

6.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].

Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.

7.
Sperm selection for assisted reproduction by prior hyaluronan binding: the HABSelect RCT.

Sperm selection for assisted reproduction by prior hyaluronan binding: the HABSelect RCT.

Kirkman-Brown J, Pavitt S, Khalaf Y, et al.

Southampton (UK): NIHR Journals Library; 2019 Feb. (Efficacy and Mechanism Evaluation, No. 6.1.)

8.
Prevention of Thalassaemias and Other Haemoglobin Disorders: Volume 1: Principles [Internet]. 2nd edition.

Prevention of Thalassaemias and Other Haemoglobin Disorders: Volume 1: Principles [Internet]. 2nd edition.

Angastiniotis M, Eleftheriou A, Galanello Ret al., authors; Old J, editor.

Nicosia (Cyprus): Thalassaemia International Federation; 2013.

9.
10.
Disease Control Priorities in Developing Countries. 2nd edition.

Disease Control Priorities in Developing Countries. 2nd edition.

Jamison DT, Breman JG, Measham AR, et al., editors.

Washington (DC): The International Bank for Reconstruction and Development / The World Bank; New York: Oxford University Press; 2006.

11.
The Clinical Effectiveness and Cost-Effectiveness of Primary Stroke Prevention in Children with Sickle Cell Disease: A Systematic Review and Economic Evaluation.

The Clinical Effectiveness and Cost-Effectiveness of Primary Stroke Prevention in Children with Sickle Cell Disease: A Systematic Review and Economic Evaluation.

Cherry MG, Greenhalgh J, Osipenko L, et al.

Southampton (UK): NIHR Journals Library; 2012 Nov. (Health Technology Assessment, No. 16.43.)

12.
Guidelines for the Management of Non-Transfusion-Dependent β-Thalassaemia [Internet]. 3rd edition.

Guidelines for the Management of Non-Transfusion-Dependent β-Thalassaemia [Internet]. 3rd edition.

Taher AT, Musallam KM, Cappellini MD.

Nicosia (Cyprus): Thalassaemia International Federation; 2023.

13.
14.
2021 Guidelines: For the Management of Transfusion Dependent Thalassaemia (TDT) [Internet]. 4th edition.

2021 Guidelines: For the Management of Transfusion Dependent Thalassaemia (TDT) [Internet]. 4th edition.

Cappellini MD, Farmakis D, Porter J, et al., editors.

Nicosia (Cyprus): Thalassaemia International Federation; 2023.

16.
Reducing Birth Defects: Meeting the Challenge in the Developing World.

Reducing Birth Defects: Meeting the Challenge in the Developing World.

Institute of Medicine (US) Committee on Improving Birth Outcomes; Bale JR, Stoll BJ, Lucas AO, editors.

Washington (DC): National Academies Press (US); 2003.

17.
Assessing Genetic Risks: Implications for Health and Social Policy.

Assessing Genetic Risks: Implications for Health and Social Policy.

Institute of Medicine (US) Committee on Assessing Genetic Risks; Andrews LB, Fullarton JE, Holtzman NA, et al., editors.

Washington (DC): National Academies Press (US); 1994.

18.
Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: A Systematic Review for the U.S. Preventive Services Task Force [Internet].

Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: A Systematic Review for the U.S. Preventive Services Task Force [Internet].

Chou R, Blazina I, Bougatsos C, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Dec. (Evidence Synthesis, No. 194.)

19.
Screening for Hemoglobinopathies in Newborns: Reaffirmation Update for the                 U.S. Preventive Services Task Force [Internet].

Screening for Hemoglobinopathies in Newborns: Reaffirmation Update for the U.S. Preventive Services Task Force [Internet].

Lin K, Barton MB.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Sep. (Evidence Syntheses, No. 52.)

20.
Toxicological Profile for Cobalt.

Toxicological Profile for Cobalt.

Atlanta (GA): Agency for Toxic Substances and Disease Registry (US); 2024 Oct.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Images search in Bookshelf

  • FIG. 2A.—A
See more (17)...

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...